Navigation Links
Society for Immunotherapy of Cancer to Host Back-to-Back Workshops on Tumor Cell Surfaceome and Bispecific T cell Engagers

The Society for Immunotherapy of Cancer (SITC) will host two timely, back-to-back workshops Sept. 29–Oct. 1, 2021, in San Diego* which will address critical challenges, facilitate innovative collaborations, and develop strategies to ensure continued momentum in drug development in the field of cancer immunotherapy.

First, the Interrogating the Tumor-Specific Surfaceome for Immune Targeting, Sept. 29–30, will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and maximization of existing techniques. Concepts ranging from the basic biology of cancer cell surface molecules to applications of drugs and cellular therapies targeting novel surface markers will be discussed, with the goal of defining the future direction of the field.

This workshop will also provide an intimate opportunity for attendees to discuss their work with experts in the field, develop collaborations and learn about novel studies of the tumor cell surfaceome. Starting April 21, individuals are encouraged to submit an abstract for an opportunity to present their research; a select number of oral abstract presentation slots will be available. Encore presentations welcome! Those abstracts not selected for oral presentation will also have the opportunity to present as a poster. Abstract submission is open to anyone working in this field.

This event will be followed by the Bispecific T cell Engagers Workshop, Sept. 30–Oct. 1, focused on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, the impact of the tumor microenvironment, and advances in conditionally-active binding. Additionally, considerations related to dosing, schedule, sequencing and combination approaches for optimizing both endogenous and synthetic immunity will be discussed.

In addition, a collaborative session, taking place the morning of Sept. 30, will allow attendees from both workshops to discuss alignment and debates in the areas of the two workshops with the focus of how to continue to advance the field.

“SITC is continually developing educational and networking opportunities to create a lasting impact on clinical practice by highlighting emerging topics relevant to immuno-oncology,” said SITC President Patrick Hwu, MD. “Together, these workshops will help attendees stay at the forefront of new technologies that will lead to the real-world application of these therapies and eventually improved patient care.”

The workshops are organized by prominent members of the immuno-oncology community, including Elizabeth Budde, MD, PhD from City of Hope; Daniel S. Chen, MD, PhD from IGM Biosciences, Inc.; James L. Gulley, MD, PhD, FACP from National Cancer Institute; Samir M. Hanash, MD, PhD from The University of Texas MD Anderson Cancer Center and Avery D. Posey Jr., PhD from University of Pennsylvania School of Medicine.

It is anticipated that the efforts of these workshops fuel innovative collaborations, disseminate important knowledge to the rest of the immunotherapy field and help assure the continued growth of immunotherapy treatments as a whole.

Registration rates, criteria for abstract submission and program schedules are available on SITC Cancer Immunotherapy CONNECT at and

*SITC is actively monitoring the incidence of COVID-19 and how it may impact our workshops. At this time, SITC is planning to host these events live (in-person) in San Diego. We will continue to assess the feasibility and safety of a live event. In the instance an in-person meeting is not feasible, the workshops will shift to a virtual format. This decision will be announced in early July 2021, and should the need arise, registrants will have the option for a refund or to convert to a virtual registration.

About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word “cure” a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at and follow us on Twitter, LinkedIn, Facebook and YouTube.

Read the full story at

Source: PRWeb
Copyright©2021 Vocus, Inc.
All rights reserved

Related biology news :

1. World Molecular Imaging Society Announces WMIC Virtual 2020 a Fully Virtual Conference
2. Mindray North America Brings Operating Room to Life at American Society of Anesthesiologists 2019 Annual Meeting
3. Nerve Damage Imaging and Single-Cell Tracking Gene Therapy are Highlights at World Molecular Imaging Society Annual Congress
4. LPA Lighting Designers Win National Honors from Illuminating Energy Society
5. RoosterBio Will Attend Society for Biomaterials Annual Meeting April 3-6, 2019
6. Society for Immunotherapy of Cancer to Host Leadership Institute Focusing on Professional Development of Women in Cancer Immunotherapy
7. Come Visit Visikol at Society of Toxicology 2019 in Baltimore at Booth 3225
8. Ondine President is Key Speaker at Royal Society of Medicine (RSM) 2018 PDT Symposium
9. Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting
10. Colorado Chapter of the FSH Society to host Walk & Roll for Facioscapulohumeral Muscular Dystrophy
11. Cowpea book published by Crop Science Society of America
Post Your Comments:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology: